Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium oxide to reduce prostate motion during radiotherapy
2007-007072-42Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in prostate cancer (PCa) comparing Magnesium oxide with Placebo (2 arms). Primary endpoint: Intrafraction prostate motion. Started Jan 2008; status: completed.
02
Drugs
magnesium oxide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2007-007072-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007072-42.